Table 2. Demographics and baseline characteristics.
| Total patients (n=19) | |
|---|---|
|
Gender | |
| Male | 7 (37%) |
| Female |
12 (63%) |
|
Age | |
| Median | 51 |
| Range |
36–70 |
|
ECOG PS | |
| 0 | 5 (26%) |
| 1 |
14 (74%) |
|
Tumour | |
| Colorectal | 7 |
| Gastric | 3 |
| Cervix | 1 |
| NSCLC | 1 |
| Poorly differentiated chondrosarcoma | 1 |
| Eccrine gland adeno | 1 |
| Renal clear cell | 1 |
| Thymoma | 1 |
| Adrenal carcinoma | 1 |
| Urothelial carcinoma | 1 |
| Anaplastic thyroidal |
1 |
|
Previous treatment | |
|
Lines of chemotherapy | |
| 0 | 1 (5%) |
| 1 | 3 (16%) |
| 2 | 4 (21%) |
| >2 | 7 (37%) |
| Unknown | 4 (21%) |
| Median |
2.5 (range 0–6) |
|
Radiotherapy | |
| Yes | 7 (37%) |
| No | 12 (63%) |
Abbreviations: ECOG PS=Eastern Cooperative Oncology Group performance status; NSCLC=non-small cell lung cancer.